PubRank

K Seidl

Author PubWeight™ 38.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol 2001 1.82
2 Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am Heart J 1999 1.66
3 Pseudoaneurysm after cardiac catheterization: therapeutic interventions and their sequelae: experience in 86 patients. Cathet Cardiovasc Diagn 1997 1.62
4 Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Invasive Cardiol 2001 1.46
5 Prospective cross-sectional study of haemostatic factors in patients with and without coronary artery disease. Blood Coagul Fibrinolysis 2002 1.41
6 Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Heart 1999 1.39
7 Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv 1999 1.39
8 [Gangrene following erroneous intra-arterial injection of dicloxacillin]. Dtsch Med Wochenschr 1971 1.08
9 Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation 2000 1.03
10 Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study Group. J Am Coll Cardiol 2000 1.03
11 Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. Am Heart J 2001 1.00
12 [Lead-related complications in 340 patients with an implantable cardiverter/defibrillator]. Z Kardiol 1999 0.98
13 Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. J Cardiovasc Electrophysiol 2001 0.95
14 Cellular architecture of the lamina propria of human seminiferous tubules. Cell Tissue Res 1990 0.92
15 In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte. Heart 2005 0.91
16 Unexpected emergence of manifest preexcitation following transcatheter ablation of concealed accessory pathways. J Cardiovasc Electrophysiol 1993 0.88
17 The neural cell adhesion molecule (NCAM) provides clues to the development of testicular Leydig cells. J Androl 1996 0.88
18 Local venous thrombosis after cardiac catheterization. Angiology 1997 0.88
19 cMeso-1, a novel bHLH transcription factor, is involved in somite formation in chicken embryos. Dev Biol 1998 0.88
20 Biosensor microprobes with integrated microfluidic channels for bi-directional neurochemical interaction. J Neural Eng 2011 0.88
21 Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II. J Cardiovasc Electrophysiol 2001 0.86
22 [Cardioversion in atrial fibrillation. Results and complications in 1,152 prospective patients. Study Group of the Working Society of Leading Cardiologic Hospital Physicians]. Med Klin (Munich) 1995 0.85
23 Chick NKx-2.3 represents a novel family member of vertebrate homologues to the Drosophila homeobox gene tinman: differential expression of cNKx-2.3 and cNKx-2.5 during heart and gut development. Mech Dev 1996 0.85
24 Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol 2000 0.83
25 Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center. Z Kardiol 2003 0.83
26 Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists. Z Kardiol 2003 0.82
27 Regulation of nerve growth factor and its low-affinity receptor (p75NTR) during myogenic differentiation. J Cell Physiol 1998 0.82
28 [Long-term outcome of AV node modulation in 387 consecutive patients with AV nodal reentrant tachycardia]. Z Kardiol 2002 0.82
29 Two-dimensional multi-channel neural probes with electronic depth control. IEEE Trans Biomed Circuits Syst 2011 0.80
30 Chicken winged-helix transcription factor cFKH-1 prefigures axial and appendicular skeletal structures during chicken embryogenesis. Dev Dyn 1998 0.80
31 Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry. Am J Cardiol 2001 0.80
32 The prognostic impact of successful cardioversion of atrial fibrillation in patients with organic heart disease. Clin Res Cardiol 2006 0.80
33 Leydig cells express neural cell adhesion molecules in vivo and in vitro. Biol Reprod 1992 0.79
34 [Delayed atrial excitation following bifocal pacemaker stimulation]. Z Kardiol 1983 0.79
35 Destruction of the preganglionic nerves by beta-bungarotoxin does not interfere with normal embryonic development of the rat adrenal medulla. Dev Biol 1986 0.79
36 Do 5-F-catheters reduce the incidence of a pseudoaneurysm? Int Angiol 1996 0.78
37 Differential effects of nerve growth factor and ciliary neuronotrophic factor on catecholamine storage and catecholamine synthesizing enzymes of cultured rat chromaffin cells. J Neurochem 1987 0.78
38 Carcinoma-in-situ cells in cultured human seminiferous tubules. Int J Androl 1991 0.78
39 Biventricular pacing in patients with ICD: how many patients are possible candidates? Thorac Cardiovasc Surg 2002 0.78
40 [Feasibility and safety of dobutamine stress echocardiography: experiences with 1,000 studies]. Z Kardiol 1996 0.78
41 Development and plasticity of adrenal chromaffin cells: cues based on in vitro studies. J Electron Microsc Tech 1989 0.77
42 Prognostic value of non-sustained ventricular tachycardias after acute myocardial infarction in the thrombolytic era: importance of combination with frequent ventricular premature beats. Z Kardiol 2003 0.77
43 [Balloon dilatation in acute myocardial infarct in routine clinical practice: results of the register of the Working Society of Leading Cardiologic Hospital Physicians in 4,625 patients]. Z Kardiol 1997 0.76
44 Plasma free fatty acid levels during cold-induced and noradrenaline-induced nonshivering thermogenesis in the Djungarian hamster. J Comp Physiol B 1985 0.76
45 Basic fibroblast growth factor (bFGF) in rodent testis. Presence of bFGF mRNA and of a 30 kDa bFGF protein in pachytene spermatocytes. FEBS Lett 1992 0.76
46 The neuro-endocrine ambiguity of sympathoadrenal cells. Int J Dev Neurosci 1989 0.76
47 [Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial]. Z Kardiol 2002 0.76
48 Microprobe array with low impedance electrodes and highly flexible polyimide cables for acute neural recording. Conf Proc IEEE Eng Med Biol Soc 2007 0.75
49 Cytochemical and biochemical characterization of neurosecretory material in the brain of an annelid, Ophryotrocha puerilis (Polychaeta). Gen Comp Endocrinol 1987 0.75
50 [Corticosteroid therapy of aggressively growing hemagiomas in infancy]. Hautarzt 1972 0.75
51 [Partial matrix resection as a treatment for ingrown nails]. Z Hautkr 1978 0.75
52 [Symmetrical, ulcerating, planotuberose haemangioma in early infancy; success of steroid therapy]. Monatsschr Kinderheilkd 1971 0.75
53 [Initial presentation of ventricular pre-excitation after catheter ablation of concealed retrograde conducting accessory atrioventricular pathways]. Z Kardiol 1992 0.75
54 [Catheter ablation of ventricular tachycardia in the left ventricular outflow tract beyond the aortic valve]. Z Kardiol 2002 0.75
55 [Measurement of the mineral content of the forearm bones in vivo]. Lijec Vjesn 1986 0.75
56 [Plastic covering of extensive 3d degree burns]. Wien Klin Wochenschr 1970 0.75
57 [Skin carcinomas in the region of the lower extremities]. Wien Klin Wochenschr 1971 0.75
58 Aluminum and parathyroid hormone concentrations in insulin-dependent diabetics on long-term hemodialysis. Nephron 1991 0.75
59 [Direct dilatation and emergency bypass operation of main branch occlusion in acute anterior wall infarct and cardiogenic shock]. Herz 1997 0.75
60 Primary angioplasty in acute myocardial infarction: differences between referred patients and those treated in hospitals with on-site facilities? J Invasive Cardiol 1999 0.75
61 [Findings of Corynebacterium equi Magnusson 1923 in connection with foal mortality in the Eastern Bohemia Region]. Vet Med (Praha) 1984 0.75
62 [The T-wave shock: a new reliable method for induction of ventricular fibrillation in ICD testing]. Z Kardiol 1995 0.75
63 [What is new in the 2009 ESC guidelines?]. Herzschrittmacherther Elektrophysiol 2011 0.75
64 [2 year follow-up of 321 patients with an implantable cardioverter/defibrillator: comparison of patients with and without atrial fibrillation]. Z Kardiol 2001 0.75
65 [Catheter-based rescue of a split pacemaker lead in the pulmonary artery]. Z Kardiol 2003 0.75
66 [Therapy of pulmonary embolism]. Dtsch Med Wochenschr 1996 0.75
67 [Treatment and sequelae of severe burns with special reference to hypertrophic scar-formation]. Wien Med Wochenschr 1973 0.75
68 [Hormone interactions in varicose veins--receptor analysis and hormone level]. Vasa 1986 0.75
69 Treatment of traumatic tattoos with various sterile brushes. J Am Acad Dermatol 1992 0.75
70 Primary percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients not included in randomized studies. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am J Cardiol 1999 0.75
71 [Fatal "overwhelming" strongyloidiasis in an immunosuppressed patient]. Lijec Vjesn 1996 0.75
72 [On the cause of death in extensive burns]. Wien Med Wochenschr 1968 0.75
73 Differences in patients with acute myocardial infarction treated with primary angioplasty or thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Clin Cardiol 1999 0.75
74 [Tricuspid valve endocarditis. Demonstration of a rare disease exemplified with 3 case reports]. Med Klin (Munich) 1997 0.75
75 [Problems in carrying out baroreflex sensitivity measurements in clinical routine practice: practicability and complications]. Z Kardiol 1997 0.75
76 [Epitheliomas of the external ear]. Z Haut Geschlechtskr 1972 0.75
77 [Primary dilatation versus thrombolysis in patients with acute myocardial infarct, not included in randomized studies. Results of the MITRA Study. Maximal Individual Optimized Therapy for Acute Myocardial Infarct]. Z Kardiol 1999 0.75
78 [1998 prognosis of left ventricular dysfunction in a maximum care non-university hospital. Analysis of the Ludwigshafen LVD Registry]. Z Kardiol 1999 0.75
79 [Diagnosis: cancer. Age of the patient: 3 years. Parent initiatives in active support of therapeutic efforts]. Fortschr Med 1989 0.75
80 [Current aspects of pacemaker therapy]. Med Klin 1979 0.75
81 MyoD and MEF2A mediate activation and repression of the p75NGFR gene during muscle development. Biochem Biophys Res Commun 1998 0.75